Climb Bio (CLYM) has an average rating of buy and mean price target of $21.27, according to analysts polled by FactSet.
What else is happening in Research?
Research
Raymond James Downgrades Enbridge to Market Perform From Outperform
Raymond James Downgrades Enbridge to Market Perform From Outperform
$ENB
Research
Phillip Securities Initiates Coverage on SpaceX With Sell Rating, $75 Price Target
SpaceX (SPCX) has an average rating of overweight and mean price target of $236.72, according to analysts polled by FactSet.Price: $108.81, Change: $-3.39, Percent Change: -3.02%
$SPCX
Research
Guggenheim Upgrades Quanta Services to Buy From Neutral, $800 Price Target
Quanta Services (PWR) has an average rating of overweight and mean price target of $799.88, according to analysts polled by FactSet.Price: $664.95, Change: $+6.97, Percent Change: +1.06%
$PWR